PHOENIX PHARMDEVICE LTD

Company Registration Number:
11971629 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2025

Period of accounts

Start date: 01 May 2024

End date: 30 April 2025

PHOENIX PHARMDEVICE LTD

Contents of the Financial Statements

for the Period Ended 30 April 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

PHOENIX PHARMDEVICE LTD

Company Information

for the Period Ended 30 April 2025




Director: Shweta Chavan
Registered office: Amba House
15 College Road
Harrow
England
HA1 1BA
Company Registration Number: 11971629 (England and Wales)

PHOENIX PHARMDEVICE LTD

Balance sheet

As at 30 April 2025


2025
£

2024
£
Fixed Assets: 18,857 25,142
Current assets: 87,959 121,404
Creditors: amounts falling due within one year: ( 5,141 ) ( 37,808 )
Net current assets (liabilities): 82,818 83,596
Total assets less current liabilities: 101,675 108,738
Total net assets (liabilities): 101,675 108,738
Capital and reserves: 101,675 108,738

PHOENIX PHARMDEVICE LTD

Balance sheet continued

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 25 July 2025
And Signed On Behalf Of The Board By:

Name: Shweta Chavan
Status: Director

The notes form part of these financial statements

PHOENIX PHARMDEVICE LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2025

  • 1. Employee Information

    Average number of employees: 2

PHOENIX PHARMDEVICE LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2025

  • 2. Off balance sheet disclosure

    No